DURATION OF DIABETES AND CARDIORENAL EFFICACY OF LIRAGLUTIDE AND SEMAGLUTIDE: A POST HOC ANALYSIS OF THE LEADER AND SUSTAIN-6 CLINICAL TRIALS

被引：0
|
作者：
Verma, Subodh [1 ]
Bain, Stephen C. [1 ]
Honore, Julie Broe [1 ]
Fries, Tea Monk [1 ]
Nauck, Michael A. [1 ]
Pratley, Richard E. [1 ]
Rasmussen, Soren [1 ]
Zinman, Bernard [1 ]
Buse, John [1 ]
机构：
[1] Novo Nordisk AS, Soborg, Denmark
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2019年 / 73卷 / 09期
关键词：
D O I：
10.1016/S0735-1097(19)32310-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1024-05
引用
收藏
页码：1704 / 1704
页数：1
相关论文
共 50 条
  • [1] Duration of diabetes and cardiorenal efficacy of liraglutide and semaglutide: A post hoc analysis of the LEADER and SUSTAIN 6 clinical trials
    Verma, Subodh
    Bain, Stephen C.
    Fries, Tea Monk
    Mazer, C. David
    Nauck, Michael A.
    Pratley, Richard E.
    Rasmussen, Soren
    Saevereid, Hans A.
    Zinman, Bernard
    Buse, John B.
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (07): : 1745 - 1751
  • [2] Effects of liraglutide and semaglutide on stroke subtypes in patients with type 2 diabetes: a post hoc analysis of the LEADER, SUSTAIN 6 and PIONEER 6 trials
    Strain, W. D.
    Holst, A. G.
    Rasmussen, S.
    Saevereid, H. A.
    James, M. A.
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S130 - S131
  • [3] Effects of liraglutide and semaglutide on stroke subtypes in patients with type 2 diabetes: a post hoc analysis of the LEADER, SUSTAIN 6 and PIONEER 6 trials
    Strain, W. D.
    Holst, A. G.
    Rasmussen, S.
    Saevereid, H. A.
    James, M. A.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 2424 - 2424
  • [4] IMPACT OF MICROVASCULAR DISEASE ON CARDIORENAL OUTCOMES IN TYPE 2 DIABETES: AN ANALYSIS FROM THE LEADER AND SUSTAIN-6 CLINICAL TRIALS
    Verma, Subodh
    Bain, Stephen C.
    Honore, Julie Broe
    Mann, Johannes F. E.
    Nauck, Michael A.
    Pratley, Richard E.
    Rasmussen, Soren
    Ripa, Maria Sejersten
    Zinman, Bernard
    Buse, John
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1687 - 1687
  • [5] Series: Cardiovascular outcome trials for diabetes drugs Semaglutide and SUSTAIN-6
    Fisher, Miles
    [J]. BRITISH JOURNAL OF DIABETES, 2021, 21 (01): : 110 - 112
  • [6] Efficacy and Safety of Semaglutide for Type 2 Diabetes by Race and Ethnicity: A Post Hoc Analysis of the SUSTAIN Trials
    DeSouza, Cyrus
    Cariou, Bertrand
    Garg, Satish
    Lausvig, Nanna
    Navarria, Andrea
    Fonseca, Vivian
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (02): : 543 - 556
  • [7] Efficacy and safety of semaglutide in subjects with type 2 diabetes by race and ethnicity: a post hoc analysis of the SUSTAIN trials
    Desouza, C.
    Garg, S.
    Cariou, B.
    Furberg, J. K.
    Navarria, A.
    Nayak, G.
    Fonseca, V.
    [J]. DIABETOLOGIA, 2018, 61 : S369 - S370
  • [8] Impact of microvascular disease on cardiorenal outcomes in type 2 diabetes: an analysis from the LEADER and SUSTAIN 6 clinical trials
    Zinman, B.
    Verma, S.
    Bain, S. C.
    Honore, J. B.
    Mann, J.
    Nauck, M. A.
    Pratley, R.
    Rasmussen, S.
    Ripa, M. Sejersten
    Buse, J. B.
    [J]. DIABETOLOGIA, 2019, 62 : S365 - S366
  • [9] Liraglutide and semaglutide improve cardiovascular and renal outcomes across most BMI categories in type 2 diabetes: results of the LEADER and SUSTAIN 6 trials
    Verma, S.
    Bain, S. C.
    Bhatt, D. L.
    Leiter, L. A.
    Mazer, C. D.
    McGuire, D. K.
    Pratley, R.
    Zinman, B.
    Lindberg, S.
    Rasmussen, S.
    Vrazic, H.
    Buse, J. B.
    [J]. DIABETOLOGIA, 2019, 62 : S560 - S560
  • [10] Efficacy and safety of semaglutide in elderly subjects with type 2 diabetes: a post hoc analysis of the SUSTAIN 7 trial
    Aroda, V. R.
    Sugimoto, D.
    Trachtenbarg, D.
    Warren, M.
    Navarria, A.
    Nayak, G.
    Nielsen, M. Abildlund
    Woo, V.
    [J]. DIABETOLOGIA, 2018, 61 : S367 - S367
12345